Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 425

1.

Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.

Thompson GR 3rd, Lewis JS 2nd, Nix DE, Patterson TF.

Med Mycol. 2019 Feb 1;57(Supplement_1):S76-S84. doi: 10.1093/mmy/myy029.

PMID:
30690601
2.

Isavuconazole in the Treatment of Coccidioidal Meningitis.

Heidari A, Quinlan M, Benjamin DJ, Laurence B, Mu A, Ngai T, Hoffman WJ, Cohen SH, McHardy I, Johnson R, Thompson GR 3rd.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02232-18. doi: 10.1128/AAC.02232-18. Print 2019 Mar.

PMID:
30559134
3.

Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort.

Thompson GR 3rd, Krois CR, Affolter VK, Everett AD, Varjonen EK, Sharon VR, Singapuri A, Dennis M, McHardy I, Yoo HS, Fedor DM, Wiederhold NP, Aaron PA, Gelli A, Napoli JL, White SD.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01384-18. doi: 10.1128/AAC.01384-18. Print 2019 Feb.

PMID:
30455235
4.

How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers.

Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH.

Clin Infect Dis. 2019 Feb 15;68(5):850-853. doi: 10.1093/cid/ciy669.

PMID:
30299481
5.

Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects.

Lindsay J, Mudge S, Thompson GR 3rd.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01723-18. doi: 10.1128/AAC.01723-18. Print 2018 Dec.

PMID:
30297369
6.

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda LL, Croos-Dabrera R, Fredericks C, Thompson GR 3rd.

Clin Infect Dis. 2018 Oct 5. doi: 10.1093/cid/ciy827. [Epub ahead of print]

PMID:
30289478
7.

Coccidioidomycosis Complement Fixation Titer Trends in the Age of Antifungals.

McHardy IH, Dinh BN, Waldman S, Stewart E, Bays D, Pappagianis D, Thompson GR 3rd.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01318-18. doi: 10.1128/JCM.01318-18. Print 2018 Dec.

8.

Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.

Thompson GR.

Atherosclerosis. 2018 Sep;276:148-154. doi: 10.1016/j.atherosclerosis.2018.07.032. Epub 2018 Jul 26. Review.

PMID:
30064057
9.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR 3rd, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG.

Open Forum Infect Dis. 2017 Sep 26;4(4):ofx200. doi: 10.1093/ofid/ofx200. eCollection 2017 Fall.

10.

Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.

Vu K, Thompson GR 3rd, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, Meyer W, Engelthaler DM, Gelli A.

Med Mycol. 2018 Oct 1;56(7):857-867. doi: 10.1093/mmy/myx135.

PMID:
29554336
11.

HIV latency is reversed by ACSS2-driven histone crotonylation.

Jiang G, Nguyen D, Archin NM, Yukl SA, Méndez-Lagares G, Tang Y, Elsheikh MM, Thompson GR 3rd, Hartigan-O'Connor DJ, Margolis DM, Wong JK, Dandekar S.

J Clin Invest. 2018 Mar 1;128(3):1190-1198. doi: 10.1172/JCI98071. Epub 2018 Feb 19.

12.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
13.

Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients?

McHardy I, Romanelli A, Harris LJ, Opp G, Gaudino R, Torres A, Polage CR, Tuscano JM, Thompson GR 3rd.

J Infect. 2018 May;76(5):500-501. doi: 10.1016/j.jinf.2018.01.010. Epub 2018 Feb 13. No abstract available.

PMID:
29408325
14.

Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation.

Hoffmann WJ, McHardy I, Thompson GR 3rd.

Mycoses. 2018 May;61(5):337-339. doi: 10.1111/myc.12749. Epub 2018 Feb 15.

PMID:
29385285
15.

Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest.

Roe CC, Bowers J, Oltean H, DeBess E, Dufresne PJ, McBurney S, Overy DP, Wanke B, Lysen C, Chiller T, Meyer W, Thompson GR 3rd, Lockhart SR, Hepp CM, Engelthaler DM.

mSphere. 2018 Jan 17;3(1). pii: e00499-17. doi: 10.1128/mSphere.00499-17. eCollection 2018 Jan-Feb.

16.

Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis.

Stewart ER, Eldridge ML, McHardy I, Cohen SH, Thompson GR 3rd.

Mycopathologia. 2018 Jun;183(3):619-622. doi: 10.1007/s11046-017-0240-7. Epub 2018 Jan 16.

PMID:
29340909
17.

Novel approaches to antifungal therapy.

Thompson GR 3rd, Patterson TF.

Am J Transplant. 2018 Feb;18(2):287-288. doi: 10.1111/ajt.14616. Epub 2018 Jan 8. No abstract available.

18.

Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol.

Thompson GR, Blom DJ, Marais AD, Seed M, Pilcher GJ, Raal FJ.

Eur Heart J. 2018 Apr 7;39(14):1162-1168. doi: 10.1093/eurheartj/ehx317.

19.

Favorable Outcome in Coccidioides Endophthalmitis-A Combined Medical and Surgical Treatment Approach.

Ling JJ, Bays DJ, Thompson GR 3rd, Moshiri A, Mannis MJ.

Cornea. 2017 Nov;36(11):1423-1425. doi: 10.1097/ICO.0000000000001353.

PMID:
28872517
20.

In Vivo 11β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia.

Thompson GR 3rd, Chang D, Wittenberg RR, McHardy I, Semrad A.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00760-17. doi: 10.1128/AAC.00760-17. Print 2017 Aug.

21.

Residual Enoxaparin Activity, Anti-Xa Levels, and Concerns About the American Society of Regional Anesthesia and Pain Medicine Anticoagulation Guidelines.

Henshaw DS, Turner JD, Forest DJ, Thompson GR, Weller RS.

Reg Anesth Pain Med. 2017 Jul/Aug;42(4):432-436. doi: 10.1097/AAP.0000000000000617.

PMID:
28492441
22.

HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.

Jiang G, Santos Rocha C, Hirao LA, Mendes EA, Tang Y, Thompson GR 3rd, Wong JK, Dandekar S.

MBio. 2017 May 2;8(3). pii: e01518-16. doi: 10.1128/mBio.01518-16.

23.

Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.

Thompson GR 3rd, Blair JE, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R.

Clin Infect Dis. 2017 Jul 15;65(2):338-341. doi: 10.1093/cid/cix318.

24.

De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.

Stoll RJ, Thompson GR, Samy MD, Blanck G.

Biomed Rep. 2017 Feb;6(2):211-216. doi: 10.3892/br.2016.826. Epub 2016 Dec 8.

25.

Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Thompson GR 3rd, Barker BM, Wiederhold NP.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02634-16. doi: 10.1128/AAC.02634-16. Print 2017 Apr.

26.

A microbiome assessment of medical marijuana.

Thompson GR 3rd, Tuscano JM, Dennis M, Singapuri A, Libertini S, Gaudino R, Torres A, Delisle JM, Gillece JD, Schupp JM, Engelthaler DM.

Clin Microbiol Infect. 2017 Apr;23(4):269-270. doi: 10.1016/j.cmi.2016.12.001. Epub 2016 Dec 9. No abstract available.

27.
28.

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

Stewart ER, Thompson GR.

J Fungi (Basel). 2016 Sep 8;2(3). pii: E25. doi: 10.3390/jof2030025. Review. Erratum in: J Fungi (Basel). 2016 Nov 04;2(4):.

29.

Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats.

Vishkautsan P, Papich MG, Thompson GR 3rd, Sykes JE.

Am J Vet Res. 2016 Sep;77(9):931-9. doi: 10.2460/ajvr.77.9.931.

PMID:
27580104
30.

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):433-42. doi: 10.1093/cid/ciw444.

31.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.

32.

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections.

Donnelley MA, Zhu ES, Thompson GR 3rd.

Infect Drug Resist. 2016 Jun 2;9:79-86. doi: 10.2147/IDR.S81416. eCollection 2016. Review.

33.

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.

Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, Maher R, Lee M, Kovanda L, Engelhardt M, Vazquez JA, Cornely OA, Perfect JR.

Clin Infect Dis. 2016 Aug 1;63(3):356-62. doi: 10.1093/cid/ciw305. Epub 2016 May 11.

34.

Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever.

Engelthaler DM, Roe CC, Hepp CM, Teixeira M, Driebe EM, Schupp JM, Gade L, Waddell V, Komatsu K, Arathoon E, Logemann H, Thompson GR 3rd, Chiller T, Barker B, Keim P, Litvintseva AP.

MBio. 2016 Apr 26;7(2):e00550-16. doi: 10.1128/mBio.00550-16.

35.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
36.

Invasive Aspergillosis: Current Strategies for Diagnosis and Management.

Cadena J, Thompson GR 3rd, Patterson TF.

Infect Dis Clin North Am. 2016 Mar;30(1):125-42. doi: 10.1016/j.idc.2015.10.015. Review.

PMID:
26897064
37.

Coccidioidomycosis.

Stockamp NW, Thompson GR 3rd.

Infect Dis Clin North Am. 2016 Mar;30(1):229-46. doi: 10.1016/j.idc.2015.10.008. Epub 2015 Dec 29. Review.

PMID:
26739609
38.

In vivo development of fluconazole resistance in serial Cryptococcus gattii isolates from a cat.

Sykes JE, Hodge G, Singapuri A, Yang ML, Gelli A, Thompson GR 3rd.

Med Mycol. 2017 Jun 1;55(4):396-401. doi: 10.1093/mmy/myw104.

PMID:
28339594
39.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
40.

Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.

Yang ML, Uhrig J, Vu K, Singapuri A, Dennis M, Gelli A, Thompson GR 3rd.

Antimicrob Agents Chemother. 2015 Dec 7;60(3):1202-7. doi: 10.1128/AAC.01777-15.

41.

Ustilago echinata: Infection in a Mixed Martial Artist Following an Open Fracture.

Stewart E, Waldman S, Sutton DA, Sanders C, Lindner J, Fan H, Wiederhold NP, Thompson GR 3rd.

Mycopathologia. 2016 Apr;181(3-4):311-4. doi: 10.1007/s11046-015-9967-1. Epub 2015 Nov 21. Review.

PMID:
26590580
42.

Mycotic Infections Acquired outside Areas of Known Endemicity, United States.

Benedict K, Thompson GR 3rd, Deresinski S, Chiller T.

Emerg Infect Dis. 2015 Nov;21(11):1935-41. doi: 10.3201/eid2111.141950. Review.

43.

Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes.

Thompson GR, Seed M, Naoumova RP, Neuwirth C, Walji S, Aitman TJ, Scott J, Myant NB, Soutar AK.

Atherosclerosis. 2015 Nov;243(1):328-33. doi: 10.1016/j.atherosclerosis.2015.09.029. Epub 2015 Sep 28.

44.

Coccidioidomycosis: Recent Updates.

Twarog M, Thompson GR 3rd.

Semin Respir Crit Care Med. 2015 Oct;36(5):746-55. doi: 10.1055/s-0035-1562900. Epub 2015 Sep 23. Review.

PMID:
26398540
45.

The Nobel dilemma: to reward scientific discovery or benefit to mankind?

Thompson GR.

QJM. 2016 Aug;109(8):513-4. doi: 10.1093/qjmed/hcv179. Epub 2015 Sep 18. Review. No abstract available.

46.

Dyslipidaemia and the military patient.

Carter NJ, Hill NE, Nicol ED, Hollis S, Patil Mead ML, Thompson GR.

J R Army Med Corps. 2015 Sep;161(3):206-10. doi: 10.1136/jramc-2015-000491. Epub 2015 Aug 5. Review.

PMID:
26246352
47.

Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.

Jiang G, Mendes EA, Kaiser P, Wong DP, Tang Y, Cai I, Fenton A, Melcher GP, Hildreth JE, Thompson GR, Wong JK, Dandekar S.

PLoS Pathog. 2015 Jul 30;11(7):e1005066. doi: 10.1371/journal.ppat.1005066. eCollection 2015 Jul.

48.

Obituary of Dr N.B. Myant.

Thompson GR.

Atherosclerosis. 2015 Jun;240(2):437-8. doi: dx.doi.org/10.1016/j.atherosclerosis.2015.03.035. No abstract available.

PMID:
26191566
49.

In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy.

Hodge G, Cohen SH, Thompson GR 3rd.

Med Mycol. 2015 Sep;53(7):749-53. doi: 10.1093/mmy/myv047. Epub 2015 Jul 10.

PMID:
26162473
50.

Coccidioides Endospores and Spherules Draw Strong Chemotactic, Adhesive, and Phagocytic Responses by Individual Human Neutrophils.

Lee CY, Thompson GR 3rd, Hastey CJ, Hodge GC, Lunetta JM, Pappagianis D, Heinrich V.

PLoS One. 2015 Jun 12;10(6):e0129522. doi: 10.1371/journal.pone.0129522. eCollection 2015.

Supplemental Content

Loading ...
Support Center